Article Details
Retrieved on: 2022-05-30 13:11:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... (UBP) has announced the approval of a Phase 2 clinical trial with novel anti-IgE monoclonal antibody UB-221 by the Taiwan Food and Drug.
Article found on: www.asiaone.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here